HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.

Abstract
The catastrophic antiphospholipid syndrome (CAPS) is a life-threating variant of the antiphospholipid syndrome characterized by the development of multiple thrombosis in a short period of time, usually ending up in the failure of function of several vital organs. Most CAPS episodes are related to a prothrombotic situation or precipitating factor such as infections, surgical procedures or malignant diseases. In patients with CAPS, the development of multiple thrombosis leads to an important cytokine release that worsens the already critical patient's situation. The disease usually involves the kidneys, the lungs and the heart, although any organ system can be affected. Although occasionally the disease affects large vessels, in the majority of cases it affects small vessels, leading to a disseminated microangiopathic syndrome resembling thrombotic thrombocytopenic purpura. Treatment is based on the administration of anticoagulants, corticosteroids, plasma exchange and/or intravenous immunoglobulins. Cyclophosphamide is recommended in those CAPS cases associated to systemic lupus erythematosus. Additionally, rituximab and eculizumab have been used in refractory cases. Mortality is still around 30% despite current treatment.
AuthorsRicard Cervera, Ignasi Rodríguez-Pintó, Gerard Espinosa
JournalJournal of autoimmunity (J Autoimmun) Vol. 92 Pg. 1-11 (08 2018) ISSN: 1095-9157 [Electronic] England
PMID29779928 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2018. Published by Elsevier Ltd.
Chemical References
  • Adrenal Cortex Hormones
  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Cytokines
  • Immunoglobulins, Intravenous
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Animals
  • Antibodies, Antiphospholipid (metabolism)
  • Anticoagulants (therapeutic use)
  • Antiphospholipid Syndrome (immunology, therapy)
  • Autoimmunity
  • Catastrophic Illness
  • Cytokines (metabolism)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Kidney (pathology)
  • Lung (pathology)
  • Myocardium (pathology)
  • Thrombosis
  • Vasculitis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: